Referral to a PH expert centre, including for right heart catheterisation, confirms the diagnosis. Supportive measures include diuretic therapy for symptoms of right heart failure and fluid retention, ...
A recent state-of-the-art review highlighted that despite significant advances, Pulmonary Hypertension (PH) patients continue ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended the ...
A recent publication in the International Journal of Cardiology, Pulmonary artery denervation in pulmonary hypertension: A comprehensive meta-analysis, has shed light on the potential of pulmonary ...
Pulmonary hypertension remains one of the most challenging and underdiagnosed conditions in respiratory medicine. However, with a well-structured approach and dedicated efforts, significant ...
Pulmonary hypertension (PH) is a rare group of serious but LOCALIZED medical conditions that can have full-body impacts if ...
This case report describes a woman in her late 50s with reversible pulmonary hypertension (PH) due to scurvy, a rare vitamin ...
Dr. Sathish Kumar Krishnan has spent years tackling a silent crisis in healthcare: pulmonary hypertension (PH), a condition that affects thousands but remains underdiagnosed and under-treated. As a ...
Group 1 pulmonary hypertension (or pulmonary arterial hypertension) is a rare, highly complex, and progressive disorder that is incurable and ultimately can lead to premature death. PAH causes ...